95 related articles for article (PubMed ID: 20113403)
1. Widespread ischemic brain lesions caused by vasculopathy associated with neurofibromatosis type 1.
Okazaki K; Kakita A; Tanaka H; Kimura K; Minagawa M; Morita T; Takahashi H
Neuropathology; 2010 Dec; 30(6):627-33. PubMed ID: 20113403
[TBL] [Abstract][Full Text] [Related]
2. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
3. Novel mutation of neurofibromatosis type 1 in a patient with cerebral vasculopathy and fatal ischemic stroke.
Tang SC; Lee MJ; Jeng JS; Yip PK
J Neurol Sci; 2006 Apr; 243(1-2):53-5. PubMed ID: 16414076
[TBL] [Abstract][Full Text] [Related]
4. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary sarcoma complicated with neurofibromatosis type 1 (NF1).
Abe Y; Hatanaka H; Kamiya T; Yamazaki H; Kijima H; Inoue H; Ueyama Y; Nakamura M
Anticancer Res; 2003; 23(1B):613-6. PubMed ID: 12680156
[TBL] [Abstract][Full Text] [Related]
6. [Developmental manifestation in children with neurofibromatosis type 1].
Cohen R; Shuper A
Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
[TBL] [Abstract][Full Text] [Related]
7. [Cerebral atrophy of vascular origin in the course of neurofibromatosis].
Pistorius MA; Enginger V; Mussini JM; Planchon B
J Mal Vasc; 1994; 19(4):315-9. PubMed ID: 7852877
[TBL] [Abstract][Full Text] [Related]
8. [Neurofibromatosis in children. Our experience].
López-Pisón J; Cuadrado-Martín M; Boldova-Aguar MC; Muñoz-Mellado A; Cabrerizo de Diago R; Peña-Segura JL
Rev Neurol; 2003 Nov 1-15; 37(9):820-5. PubMed ID: 14606048
[TBL] [Abstract][Full Text] [Related]
9. Incidence, types, and management of cancer in patients with neurofibromatosis.
Cohen BH; Rothner AD
Oncology (Williston Park); 1989 Sep; 3(9):23-30; discussion 34, 37-8. PubMed ID: 2518324
[TBL] [Abstract][Full Text] [Related]
10. Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.
Faravelli F; Upadhyaya M; Osborn M; Huson SM; Hayward R; Winter R
J Med Genet; 1999 Dec; 36(12):893-6. PubMed ID: 10593996
[TBL] [Abstract][Full Text] [Related]
11. Poliosis circumscripta associated with neurofibromatosis 1.
Sandoval-Tress C; Nava-Jiménez G
Australas J Dermatol; 2008 Aug; 49(3):167-8. PubMed ID: 18638227
[TBL] [Abstract][Full Text] [Related]
12. Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1.
Edwards PC; Fantasia JE; Saini T; Rosenberg TJ; Sachs SA; Ruggiero S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):765-72. PubMed ID: 17138179
[TBL] [Abstract][Full Text] [Related]
13. [Pheochromocytoma associated with neurofibromatosis 1: a report of two cases].
Sano F; Fujikawa N; Hirai K; Ueki T; Kitami K
Hinyokika Kiyo; 2005 Dec; 51(12):793-5. PubMed ID: 16440725
[TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
Buteică E; Stoicescu I; Burada F; Stănoiu B
Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
[TBL] [Abstract][Full Text] [Related]
15. Early-onset stroke in two siblings with Neurofibromatosis type 1.
Rukavina K; Töpper R; Kunze A; Hess A; Glatzel M; Valdueza JM; Farschtschi S; Hagel C
Eur J Med Genet; 2019 Oct; 62(10):103710. PubMed ID: 31279841
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations in neurofibromatosis type 1.
Miraglia E; Moliterni E; Iacovino C; Roberti V; Laghi A; Moramarco A; Giustini S
Clin Ter; 2020; 171(5):e371-e377. PubMed ID: 32901776
[TBL] [Abstract][Full Text] [Related]
17. [Managing children with neurofibromatosis type 1: what should we look for?].
Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
[TBL] [Abstract][Full Text] [Related]
18. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
[TBL] [Abstract][Full Text] [Related]
19. [Pituitary adenoma associated with neurofibromatosis type 1: case report].
Kurozumi K; Tabuchi A; Ono Y; Tamiya T; Ohmoto T; Furuta T; Hamasaki S
No Shinkei Geka; 2002 Jul; 30(7):741-5. PubMed ID: 12134671
[TBL] [Abstract][Full Text] [Related]
20. Ullrich-Turner syndrome and neurofibromatosis-1.
Schorry EK; Lovell AM; Milatovich A; Saal HM
Am J Med Genet; 1996 Dec; 66(4):423-5. PubMed ID: 8989459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
